Evidence map›Paper›PMID 37256383›Full record

SynthesisJournal of cancer research and clinical oncology2023

Postmastectomy radiotherapy in patients with T

Meng Luo, Yao Jin, Chunjing Xu, Huihui Chen, Kun Zhang, Qiang Chen, Chencan Jin, Jinglu Lu, Jing Wang, Jia Huang and 5 more

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Journal of cancer research and clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Meng Luo *Department of Breast Surgery and Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yao Jin *Department of Breast Surgery and Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Chunjing Xu *Department of Breast Surgery, Zhejiang Hospital, Hangzhou, China.
Huihui ChenDepartment of Breast Surgery and Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Kun ZhangDepartment of Breast Surgery and Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Qiang ChenDepartment of Breast Surgery and Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Chencan JinDepartment of Nursing, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Jinglu LuDepartment of Breast Surgery and Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Jing WangDepartment of Breast Surgery and Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Jia HuangThe Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang University School of Medicine, Hangzhou, China.
Hao DengDepartment of Breast Surgery and Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Weili JinDepartment of Breast Surgery and Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Shu ZhengThe Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang University School of Medicine, Hangzhou, China.
Yiding ChenDepartment of Breast Surgery and Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. ydchen@zju.edu.cn.
Jiaojiao ZhouDepartment of Breast Surgery and Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. zhoujj@zju.edu.cn.
Second Affiliated Hospital of Zhejiang University · CNZhejiang Cancer Hospital · CNZhejiang University · CNZhejiang Hospital · CN

Funding

Medical Science and Technology Project of Zhejiang Province 2022RC174National Natural Science Foundation of China 82172344Natural Science Foundation of Zhejiang Province LY21H160039
6 · The paper itself

Abstract

purposePostmastectomy radiotherapy (PMRT) in patients with T PATIENTS AND

methodsFrom January 2006 to May 2017, 2606 female breast cancer patients underwent mastectomy in our medical center, among whom 402 patients of T

resultsIn the study of our center, no statistically significant difference was observed between the T

conclusionPMRT did not affect the survival of T

Indexed as

Breast NeoplasmsFemaleHumansMastectomyNeoplasm Recurrence, LocalNeoplasm StagingRadiotherapy, AdjuvantRetrospective StudiesBreast cancerDisease-free survivalOverall survivalPostmastectomy radiotherapy

Identifiers

PMID37256383
PMCPMC11796587
OpenAlexW4378782931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.